DREADD agonist 21 dihydrochloride is used as a potent and selective agonist for muscarinic DREADDs (hM1Dq, hM3Dq, and hM4Di) to activate engineered G protein-coupled receptors in chemogenetic studies; it effectively activates neuronal hM3Dq in vivo in mice and exhibits excellent bioavailability, pharmacokinetic properties, and brain penetrability, making it suitable for in vivo chemogenetic manipulation of neuronal activity.